search
Insilico Medicine
Trends
- 1Insilico Medicine signs multimillion AI drug discovery deal▼Insilico Medicine strikes tens-of-millions AI co-development deal with unnamed foundation-model lab
Insilico Medicine, the Hong Kong-based clinical-stage biotech known for using generative AI in drug discovery, has struck a co-development deal worth tens of millions of dollars with an unnamed foundation-model laboratory. The partnership will focus on building AI models for drug development. The identity of the partner lab has not been disclosed.